Martin Rossor
#72,116
Most Influential Person Now
British neurologist
Martin Rossor's AcademicInfluence.com Rankings
Martin Rossormedical Degrees
Medical
#783
World Rank
#1029
Historical Rank
Neurology
#67
World Rank
#113
Historical Rank
Download Badge
Medical
Why Is Martin Rossor Influential?
(Suggest an Edit or Addition)According to Wikipedia, Martin Neil Rossor , is a British clinical neurologist with a specialty interest in degenerative dementias and familial disease. Career He is professor emeritus and principal research associate at the UCL Queen Square Institute of Neurology, honorary consultant neurologist at the National Hospital for Neurology and Neurosurgery, and was the national director for Dementia Research for the National Institute for Health Research in the UK.
Martin Rossor's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) (12716)
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease (1991) (4571)
- Current concepts in mild cognitive impairment. (2001) (4482)
- Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria (2007) (4004)
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. (2011) (3651)
- Clinical and biomarker changes in dominantly inherited Alzheimer's disease. (2012) (2815)
- Revising the definition of Alzheimer's disease: a new lexicon (2010) (1793)
- Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease (2011) (1701)
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes (2009) (1441)
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2013) (1388)
- Analysis of shared heritability in common disorders of the brain (2016) (1385)
- Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene (1991) (1219)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. (2004) (1005)
- A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. (2003) (799)
- Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia (2005) (764)
- Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples (1999) (745)
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study (2010) (705)
- Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI (2002) (667)
- Neuropeptide Y distribution in human brain (1983) (665)
- Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease (2001) (656)
- Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. (1996) (644)
- The prevalence and causes of dementia in people under the age of 65 years (2003) (642)
- Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline (2007) (639)
- Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease (2010) (587)
- The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1 (1999) (573)
- Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease (2005) (543)
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease (2019) (487)
- Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study (2008) (482)
- The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families (1995) (461)
- Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images (2001) (459)
- A post-mortem study of the cholinergic and GABA systems in senile dementia. (1982) (449)
- Conversion of amyloid positive and negative MCI to AD over 3 years (2009) (425)
- Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis (2015) (420)
- Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type (1980) (418)
- Neurochemical characteristics of early and late onset types of Alzheimer's disease. (1984) (417)
- The heritability and genetics of frontotemporal lobar degeneration (2009) (415)
- Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder (1990) (413)
- Automatic Differentiation of Anatomical Patterns in the Human Brain: Validation with Studies of Degenerative Dementias (2002) (412)
- The diagnosis of young-onset dementia (2010) (412)
- Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features (2012) (410)
- The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup (2011) (410)
- Amyloid, hypometabolism, and cognition in Alzheimer disease (2007) (396)
- Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype (2001) (387)
- Increased brain dopamine and dopamine receptors in schizophrenia. (1982) (385)
- Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. (2000) (367)
- Visualisation and quantification of rates of atrophy in Alzheimer's disease (1996) (366)
- Correlation between rates of brain atrophy and cognitive decline in AD (1999) (360)
- Consensus classification of posterior cortical atrophy (2017) (350)
- Advanced online publication. (2005) (336)
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer’s Disease (2014) (335)
- Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease (2013) (318)
- Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study (2018) (316)
- Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. (2013) (309)
- Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration (2011) (301)
- Common variants at ABCA 7 , MS 4 A 6 A / MS 4 A 4 E , EPHA 1 , CD 33 and CD 2 AP are associated with Alzheimer ’ s disease (2011) (292)
- Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease (1980) (284)
- A locus for familial early–onset Alzhelmer's disease on the long arm of chromosome 14, proximal to the α1–antichymotrypsin gene (1992) (277)
- The clinical profile of right temporal lobe atrophy. (2004) (274)
- A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene (1995) (272)
- Microglial activation and amyloid deposition in mild cognitive impairment (2009) (269)
- Loss of pigmented dopamine-β-hydroxylase positive cells from locus coeruleus in senile dementia of alzheimer's type (1983) (267)
- EFNS‐ENS Guidelines on the diagnosis and management of disorders associated with dementia (2012) (267)
- PREDISPOSING LOCUS FOR ALZHEIMER'S DISEASE ON CHROMOSOME 21 (1989) (267)
- Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. (1998) (264)
- Frontotemporal dementia and its subtypes: a genome-wide association study (2014) (262)
- Early onset familial Alzheimer’s disease (2003) (253)
- Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease (1995) (252)
- Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration (2009) (252)
- Research priorities to reduce the global burden of dementia by 2025 (2016) (249)
- Prion dementia without characteristic pathology (1990) (235)
- FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration (2010) (230)
- Neurotransmitters and CNS disease. Dementia. (1982) (227)
- Progressive logopenic/phonological aphasia: Erosion of the language network (2010) (226)
- Posterior cortical atrophy (2012) (224)
- A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. (2008) (224)
- Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations☆ (2010) (222)
- Molecular nexopathies: a new paradigm of neurodegenerative disease (2013) (216)
- Rates of global and regional cerebral atrophy in AD and frontotemporal dementia (2001) (215)
- Young onset dementia (2004) (212)
- Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia (2001) (211)
- The substantia innominata in alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes (1982) (205)
- Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial (2009) (201)
- C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis (2015) (201)
- Amyloid β protein (Aβ) deposition in chromosome 14–linked Alzheimer's disease: Predominance of Aβ42(43) (1996) (194)
- Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease. (1986) (194)
- Neurofilament light chain: a biomarker for genetic frontotemporal dementia (2016) (189)
- Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. (1996) (187)
- Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. (2012) (186)
- Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C‐PIB positron emission tomography study (2006) (183)
- Neurofilament inclusion body disease: a new proteinopathy? (2003) (180)
- Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer’s disease (2013) (179)
- Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. (1992) (179)
- Assessing the onset of structural change in familial Alzheimer's disease (2003) (175)
- Familial non-specific dementia maps to chromosome 3. (1995) (172)
- In vivo detection of microglial activation in frontotemporal dementia (2004) (171)
- Frontotemporal dementia (2013) (169)
- Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease (1999) (166)
- Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease (1999) (163)
- Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease (2018) (163)
- Olfactory threshold in Parkinson's disease. (1987) (161)
- Frontotemporal lobar degeneration and ubiquitin immunohistochemistry (2004) (159)
- Primary progressive aphasia: a clinical approach (2018) (157)
- Alzheimer's patients engage an alternative network during a memory task (2005) (156)
- Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. (2006) (156)
- Heterogeneity in progressive aphasia due to focal cortical atrophy. A clinical and PET study. (1990) (155)
- Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease (1996) (155)
- The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. (2005) (155)
- Correlating familial Alzheimer's disease gene mutations with clinical phenotype. (2010) (152)
- Word-finding difficulty: a clinical analysis of the progressive aphasias. (2007) (150)
- NEURONAL DEGENERATION IN LOCUS CERULEUS AND CORTICAL CORRELATES OF ALZHEIMER DISEASE (1987) (150)
- Alzheimer's pathology in primary progressive aphasia (2012) (150)
- Angiotensin Converting Enzyme in Alzheimer's Disease: Increased Activity in Caudate Nucleus and Cortical Areas (1982) (148)
- Pick's disease is associated with mutations in the tau gene (2000) (146)
- Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer’s disease: a case series (2016) (145)
- A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies (2000) (144)
- Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study (2018) (139)
- Serum neurofilament light in familial Alzheimer disease (2017) (138)
- Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease (2004) (137)
- Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia. (1984) (136)
- Volumetric MRI and cognitive measures in Alzheimer disease (2008) (136)
- Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. (2000) (134)
- Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. (2005) (134)
- Vasopressin, oxytocin and neurophysins in the human brain and spinal cord (1984) (130)
- Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core. (1981) (130)
- Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type (1984) (128)
- Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study (2019) (128)
- Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. (2013) (127)
- Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research (2012) (126)
- Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea (1988) (125)
- Reduced corticol choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide (1980) (124)
- VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration (2007) (123)
- The grasp and other primitive reflexes (2003) (121)
- Intracranial volume and Alzheimer disease: evidence against the cerebral reserve hypothesis. (2000) (121)
- TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions (2014) (119)
- Topographical short‐term memory differentiates Alzheimer's disease from frontotemporal lobar degeneration (2009) (119)
- The genetic and pathological classification of familial frontotemporal dementia. (2001) (117)
- Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates (2004) (116)
- The genetic causes of basal ganglia calcification, dementia, and bone cysts (2005) (116)
- Huntington's disease phenocopies are clinically and genetically heterogeneous (2008) (115)
- The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases (1999) (115)
- Effect of Lamivudine on Human T-Cell Leukemia Virus Type 1 (HTLV-1) DNA Copy Number, T-Cell Phenotype, and Anti-Tax Cytotoxic T-Cell Frequency in Patients with HTLV-1-Associated Myelopathy (1999) (115)
- Progressive cerebral atrophy in MS (2000) (113)
- Measuring atrophy in Alzheimer disease (2005) (113)
- Regional Distribution of Neurotensin in Human Brain (1982) (112)
- Assessing quality of life in dementia: Preliminary psychometric testing of the Quality of Life Assessment Schedule (QOLAS) (2001) (112)
- Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects (1980) (112)
- Syndromes of nonfluent primary progressive aphasia (2010) (111)
- Progressive degeneration of the right temporal lobe studied with positron emission tomography. (1990) (111)
- Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT (2015) (110)
- Brain biopsy in dementia. (2005) (110)
- Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease (2003) (109)
- Familial Alzheimer's disease. (1992) (109)
- MRS shows abnormalities before symptoms in familial Alzheimer disease (2006) (108)
- Chromosome 3 linked frontotemporal dementia (FTD-3) (2002) (106)
- Functional connectivity in autosomal dominant and late-onset Alzheimer disease. (2014) (106)
- Distribution of Cholecystokinin‐Like Peptides in the Human Brain (1982) (106)
- Patterns of longitudinal brain atrophy in the logopenic variant of primary progressive aphasia (2013) (105)
- Early onset familial Alzheimer’s disease: Mutation frequency in 31 families (2002) (104)
- Advanced online publication (2002) (103)
- Profiles of white matter tract pathology in frontotemporal dementia (2014) (103)
- Reduced cortical thickness in the posterior cingulate gyrus is characteristic of both typical and atypical Alzheimer's disease. (2010) (103)
- Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. (2005) (102)
- Monitoring cognitive changes: psychometric properties of six cognitive tests. (2004) (102)
- Transmission and age‐at‐onset patterns in familial Alzheimer's disease (1990) (100)
- A Systematic Review and Meta-Analysis of CSF Neurofilament Protein Levels as Biomarkers in Dementia (2007) (97)
- Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study (2019) (96)
- Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation (1996) (96)
- Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. (1997) (93)
- A new variant of prion disease (1996) (93)
- White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) (93)
- Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers. (2011) (93)
- R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia (2014) (92)
- White matter tract signatures of the progressive aphasias (2013) (92)
- Delusions and hallucinations in dementia with Lewy bodies: Worsening with memantine (2005) (91)
- Chromosome 14 linked familial Alzheimer's disease. A clinico-pathological study of a single pedigree. (1995) (90)
- Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology (1992) (89)
- Dementia and Parkinson's disease--pathological and neurochemical considerations. (1986) (87)
- Does Alzheimer’s Disease Affect Hippocampal Asymmetry? Evidence from a Cross-Sectional and Longitudinal Volumetric MRI Study (2005) (86)
- Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease (2016) (86)
- Pain and temperature processing in dementia: a clinical and neuroanatomical analysis (2015) (86)
- Age and histopathologic heterogeneity in Alzheimer's disease. Evidence for subtypes. (1987) (86)
- Progressive loss of speech output and orofacial dyspraxia associated with frontal lobe hypometabolism. (1991) (85)
- Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities. (2002) (85)
- Reduction in cholecystokinin-like immunoreactivity in the basal ganglia in Huntington's disease (1980) (82)
- Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions (2003) (82)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. (2018) (81)
- Tracking progression in frontotemporal lobar degeneration (2008) (79)
- Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series (2012) (78)
- Some workmen can blame their tools: artistic change in an individual with Alzheimer's disease (2001) (78)
- Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene. (2013) (78)
- A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. (2011) (77)
- Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP717 Val-->Ile. (1992) (77)
- Receptive prosody in nonfluent primary progressive aphasias (2012) (76)
- ARGININE VASOPRESSIN AND CHOLINE ACETYLTRANSFERASE IN BRAINS OF PATIENTS WITH ALZHEIMER TYPE SENILE DEMENTIA (1980) (76)
- Apolipoprotein e genotype modifies the phenotype of Alzheimer disease. (2006) (75)
- A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease (1996) (75)
- Prospective study of HTLV-I infection in an initially asymptomatic cohort. (1999) (75)
- The isolation of calculation skills (2004) (74)
- Longitudinal Patterns of Regional Change on Volumetric MRI in Frontotemporal Lobar Degeneration (2004) (74)
- Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer type. (1981) (74)
- Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type (1986) (74)
- Vulnerability to neuroleptic side effects in frontotemporal lobar degeneration (2003) (73)
- Serum neurofilament light in familial Alzheimer disease A marker of early neurodegeneration (73)
- Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic (2018) (73)
- DOPAMINE RECEPTORS AND SCHIZOPHRENIA: DRUG EFFECT OR ILLNESS? (1980) (72)
- Apolipoprotein E genotyping in Alzheimer's disease (1996) (72)
- Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease (2018) (71)
- CHOLINERGIC DEFICIT IN FRONTAL CEREBRAL CORTEX IN ALZHEIMER'S DISEASE IS AGE DEPENDENT (1981) (70)
- Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network. (2015) (70)
- Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action. (1983) (70)
- Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls (2013) (70)
- Clinical and positron emission tomographic studies in the 'extrapyramidal syndrome' of dementia of the Alzheimer type. (1990) (69)
- Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative. (1995) (69)
- Atrophy of the Hippocampal Formation in Early Familial Alzheimer's Disease (1996) (68)
- Apraxia in progressive nonfluent aphasia (2009) (68)
- Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component (2009) (68)
- Increased S100β in the cerebrospinal fluid of patients with frontotemporal dementia (1997) (68)
- Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study (2018) (68)
- The pattern of atrophy in familial Alzheimer disease (2013) (68)
- Extrahypothalamic vasopressin in human brain (1981) (67)
- Measuring disease progression in frontotemporal lobar degeneration (2010) (67)
- Validation of next-generation sequencing technologies in genetic diagnosis of dementia (2014) (66)
- ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families. (1998) (66)
- Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. European Federation of Neurological Societies. (2000) (65)
- Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2009) (64)
- Structural neuroanatomy of tinnitus and hyperacusis in semantic dementia (2011) (64)
- The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy. (1994) (63)
- Purkinje cell loss and astrocytosis in the cerebellum in familial and sporadic Alzheimer's disease (1996) (63)
- Clinical features of frontotemporal dementia due to the intronic tau 10+16 mutation (2002) (62)
- Alien hand sign in association with Alzheimer's histopathology. (1993) (61)
- The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. (2012) (61)
- Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study (2020) (61)
- Genetic Variability in CLU and Its Association with Alzheimer's Disease (2010) (61)
- Application of automated medial temporal lobe atrophy scale to Alzheimer disease. (2007) (60)
- Epilepsy presenting as AD: Neuroimaging, electroclinical features, and response to treatment (2002) (60)
- CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline (2018) (59)
- Dopamine D-1 and D-2 receptors in Huntington's disease. (1983) (59)
- BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease. (2016) (59)
- Molecular Genetic Characterisation of Frontotemporal Dementia on Chromosome 3 (1999) (58)
- Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy (2019) (57)
- Neurological manifestations of autosomal dominant familial Alzheimer’s disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS) (2016) (57)
- Transmission and age-at-onset patterns in familial Alzheimer??s disease: evidence for heterogeneity (1991) (56)
- Association between autoimmune thyroid disease and Familial Alzheimers disease (1991) (56)
- Transportin1: a marker of FTLD-FUS (2011) (55)
- Familial dementia with swollen achromatic neurons and corticobasal inclusion bodies: a clinical and pathological study (1996) (55)
- Novel L284R MAPT Mutation in a Family with an Autosomal Dominant Progressive Supranuclear Palsy Syndrome (2010) (55)
- Hereditary leukoencephalopathy with axonal spheroids: a spectrum of phenotypes from CNS vasculitis to parkinsonism in an adult onset leukodystrophy series (2015) (54)
- Functional cognitive disorder: dementia's blind spot. (2020) (54)
- The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort. (2004) (53)
- Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis (2019) (53)
- SUBSTANCE P AND ENKEPHAUNS IN SPINAL CORD AFTER LIMB AMPUTATION (1982) (53)
- Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. (2008) (53)
- Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. (2002) (53)
- Lewy bodies in the brain of two members of a family with the 717 (Val to Ile) mutation of the amyloid precursor protein gene (1994) (52)
- Transient ischaemic attacks are associated with increased rates of global cerebral atrophy (2003) (51)
- Opiate and neuroleptic receptor alterations in human schizophrenic brain tissue. (1980) (51)
- Presymptomatic cortical thinning in familial Alzheimer disease (2016) (51)
- Clinical features of sporadic and familial Alzheimer's disease. (1996) (51)
- The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease (2017) (51)
- Extensive and temporally ungraded retrograde amnesia in encephalitis associated with antibodies to voltage-gated potassium channels. (2007) (51)
- Recommended minimum data to be collected in research studies on Alzheimer's disease. The MRC (UK) Alzheimer's Disease Workshop Steering Committee. (1989) (51)
- Chromosome 14 familial Alzheimer’s disease: the clinical and neuropathological characteristics of a family with a leucine→serine (L250S) substitution at codon 250 of the presenilin 1 gene (1998) (51)
- Mapping the progression of progranulin-associated frontotemporal lobar degeneration (2008) (51)
- A Volumetric Magnetic Resonance Imaging Study of the Amygdala in Frontotemporal Lobar Degeneration and Alzheimer’s Disease (2005) (50)
- Detailed volumetric analysis of the hypothalamus in behavioral variant frontotemporal dementia (2015) (50)
- Quantitative magnetization transfer imaging in Alzheimer disease. (2007) (50)
- Neurology: A Queen Square Textbook (2009) (50)
- Sequencing of exons 16 and 17 of the β-amyloid precursor protein gene in 14 families with early onset Alzheimer's disease fails to reveal mutations in the β-amyloid sequence (1991) (48)
- Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer's disease. (1994) (48)
- Alzheimer's disease in the 100 years since Alzheimer's death. (2015) (48)
- An automated algorithm for the computation of brain volume change from sequential MRIs using an iterative principal component analysis and its evaluation for the assessment of whole-brain atrophy rates in patients with probable Alzheimer's disease (2004) (48)
- Age of onset in familial early onset Alzheimer's disease correlates with genetic aetiology. (1993) (48)
- Presymptomatic studies in genetic frontotemporal dementia (2013) (47)
- Morphological overlap between corticobasal degeneration and Pick's disease: A clinicopathological report (1995) (47)
- Insertions in the prion protein gene in atypical dementias (1991) (47)
- Delusions in frontotemporal lobar degeneration (2009) (47)
- Plasma levodopa, dopamine and therapeutic response following levodopa therapy of Parkinsonian patients (1980) (47)
- Neuropathologic variation in frontotemporal dementia due to the intronic tau 10+16 mutation (2002) (47)
- Analysis of tau haplotypes in Pick’s disease (2002) (47)
- Amnesia, cerebral atrophy, and autoimmunity (2003) (47)
- Magnetic resonance imaging in central pontine myelinolysis. (1989) (47)
- Rates of hemispheric and lobar atrophy in the language variants of frontotemporal lobar degeneration. (2012) (47)
- Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease (2018) (46)
- Mutation in the tau exon 10 splice site region in familial frontotemporal dementia (1999) (46)
- The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease (2019) (46)
- Genetics of the dementias (2002) (46)
- Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease (2017) (46)
- A presenilin 1 R278I mutation presenting with language impairment (2004) (45)
- Clinical trial designs for demonstrating disease-course-altering effects in dementia. (1998) (45)
- Autonomic failure preceding dementia with Lewy bodies (2000) (44)
- Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations. (2013) (44)
- Combining short interval MRI in Alzheimer’s disease (2006) (44)
- Test-retest reliability, practice effects and reliable change indices for the recognition memory test. (2003) (44)
- Auditory hedonic phenotypes in dementia: A behavioural and neuroanatomical analysis (2015) (43)
- A comparison of purposeless movements in psychiatric patients treated with antipsychotic drugs, and normal individuals. (1983) (43)
- Cases of Alzheimer's disease due to deletion of exon 9 of the presenilin‐1 gene show an unusual but characteristic β‐amyloid pathology known as ‘cotton wool’ plaques (2001) (42)
- Neuroanatomical profiles of personality change in frontotemporal lobar degeneration (2011) (42)
- Selective Sparing of Verb Naming in a Case of Severe Alzheimer's Disease (1999) (42)
- EEG abnormalities in frontotemporal lobar degeneration (2004) (42)
- Clinical and Neuroimaging Features of Familial Alzheimer's Disease a (1996) (42)
- A pathogenic progranulin mutation and C9orf72 repeat expansion in a family with frontotemporal dementia (2014) (41)
- Confirmation that familial clustering and age of onset in late onset Alzheimer's disease are determined at the apolipoprotein E locus (1994) (41)
- Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration (2009) (41)
- Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease. (2021) (41)
- Alzheimer's Disease Families with Amyloid Precursor Protein Mutations a (1993) (41)
- CANDID—counselling and diagnosis in dementia: a national telemedicine service supporting the care of younger patients with dementia (1998) (41)
- Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer’s disease (2017) (40)
- Sporadic fatal insomnia: A case study (2000) (40)
- Dementia wellbeing and COVID‐19: Review and expert consensus on current research and knowledge gaps (2021) (40)
- GENETICS OF ALZHEIMERS-DISEASE (1990) (40)
- The Dementias Platform UK (DPUK) Data Portal (2019) (40)
- New year, new editorial team (2004) (40)
- Cerebellar pathology in sporadic and familial Alzheimer's disease including APP 717 (Val→Ile) mutation cases: A morphometric investigation (1996) (40)
- Neurotensin in human brain: Regional distribution and effects of neurological illness (1985) (39)
- The Quantitative Assessment of Apraxic Deficits in Alzheimer's Disease (2007) (39)
- Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group. (1997) (39)
- THE MOLECULAR-GENETICS OF ALZHEIMERS-DISEASE (1989) (39)
- No Evidence for Lateral Asymmetry of Neurotransmitters in Post‐Mortem Human Brain (1980) (38)
- The clinical and neuroanatomical phenotype of FUS associated frontotemporal lobar degeneration (2010) (38)
- Pick’s disease: A clinical overview (2001) (38)
- Dissecting IWG-2 typical and atypical Alzheimer’s disease: insights from cerebrospinal fluid analysis (2015) (38)
- Mapping the onset and progression of atrophy in familial frontotemporal lobar degeneration (2005) (38)
- Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurements. (2007) (38)
- RECOMMENDED MINIMUM DATA TO BE COLLECTED IN RESEARCH STUDIES ON ALZHEIMERS-DISEASE (1989) (37)
- Mental symptoms in Huntington's disease and a possible primary aminergic neuron lesion. (1980) (37)
- Prion protein immunocytochemistry helps to establish the true incidence of prion diseases (1992) (37)
- Progressive frontal gait disturbance with atypical Alzheimer’s disease and corticobasal degeneration (1999) (37)
- Consent recommendations for research and international data sharing involving persons with dementia (2018) (37)
- Predicting sporadic Alzheimer’s disease progression via inherited Alzheimer’s disease-informed machine-learning (2020) (35)
- A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromes (2011) (35)
- Hereditary Vascular Dementia Linked to Notch 3 Mutations: CADASIL in British Families (2000) (35)
- Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study (2019) (35)
- Alzheimer's disease due to an intronic presenilin-1 (PSEN1 intron 4) mutation: A clinicopathological study. (2000) (35)
- Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort (2018) (34)
- Cognitive Impairment and Dementia (2009) (34)
- Bilateral nucleus basalis of Meynert deep brain stimulation for dementia with Lewy bodies: A randomised clinical trial (2020) (34)
- Creutzfeldt-Jakob disease in a young woman (1996) (34)
- Altered body schema processing in frontotemporal dementia with C9ORF72 mutations (2014) (33)
- Pathological correlates of white matter hyperintensities in a case of progranulin mutation associated frontotemporal dementia (2018) (33)
- NeuroGrid: using grid technology to advance neuroscience (2005) (33)
- Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43). (1996) (33)
- Benzodiazepine receptors: The effect of GABA on their characteristics in human brain and their alteration in Huntington's disease (1980) (33)
- Extrahypothalamic vasopressin is unchanged in Parkinson's disease and Huntington's disease (1982) (32)
- Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series (2018) (32)
- Positron Emission Tomography in Familial Alzheimer Disease (1995) (31)
- The regional distribution and chromatographic behaviour of somatostatin in human brain (1981) (31)
- Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales (2018) (31)
- Amaurosis fugax in young people. (1992) (31)
- Dementia with Lewy bodies studied with positron emission tomography. (2001) (30)
- Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial magnetic resonance images (2002) (30)
- Alteractions in brain opiate receptors in Parkinson's disease (1979) (30)
- Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease. (2019) (30)
- A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers (2018) (30)
- Report of an International Psychogeriatric Association Special Meeting Work Group; Under the Cosponsorship of Alzheimer's Disease International, the European Federation of Neurological Societies, the World Health Organization, and the World Psychiatric Association (1997) (30)
- Sciatic nerve damage due to toilet seat entrapment: another Saturday night palsy. (1989) (29)
- Neurotransmitters of the cerebral cortex in senile dementia of Alzheimer type. (1982) (29)
- Neuropeptides and dementia. (1986) (29)
- Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2017) (29)
- Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. (1995) (29)
- The neuropsychology of variant CJD: a comparative study with inherited and sporadic forms of prion disease (2005) (28)
- Typical clinical features (2007) (28)
- Molecular pathology of Alzheimer's disease. (1993) (28)
- Hemorrhage is uncommon in new Alzheimer family with Flemish amyloid precursor protein mutation (2004) (28)
- Neologistic jargon aphasia and agraphia in primary progressive aphasia (2009) (28)
- Phenotypic variability in the brains of a family with a prion disease characterized by a 144‐base pair insertion in the prion protein gene (2003) (28)
- Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)--confirmation by cerebral biopsy in 2 cases. (1995) (28)
- “—but who is that on the other side of you?” Extracampine hallucinations revisited (2002) (28)
- Transmitter deficits in Alzheimer's disease (1985) (28)
- Acquired Brown's syndrome: an unusual cause. (1985) (27)
- Cognitive profile in dementia associated with vitamin B12 deficiency due to pernicious anaemia (1999) (27)
- Neurological complications associated with parenteral treatment: central pontine myelinolysis and Wernicke's encephalopathy. (1986) (27)
- Pathology of familial Alzheimer's disease with Lewy bodies. (1997) (27)
- Contribution of cerebral amyloid angiopathy to Alzheimer ’ s disease (2003) (27)
- Ornithine aminotransferase in Huntington's disease (1982) (27)
- Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study (2017) (27)
- βA4 protein deposition in familial Alzheimer's disease with the mutation in codon 717 of the βA4 amyloid precursor protein gene and sporadic Alzheimer's disease (1993) (27)
- Neurological Manifestations of Autosomal Dominant Alzheimer’s Disease from the DIAN cohort and a meta-analysis (2016) (27)
- Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease (2015) (26)
- PRESENILE DEMENTIA ASSOCIATED WITH MOSAIC TRISOMY 21 IN A PATIENT WITH A DOWN SYNDROME CHILD (1989) (26)
- Dementia and Cognitive Impairment (2016) (26)
- Management of dementia. (1993) (26)
- Sequence analysis of tau in familial and sporadic progressive supranuclear palsy (2002) (26)
- Toward common mechanisms for risk factors in Alzheimer's syndrome (2017) (26)
- Extending the clinical research network approach to all of healthcare. (2011) (26)
- Evidence of a founder effect in families with frontotemporal dementia that harbor the tau +16 splice mutation (2004) (26)
- Differential early subcortical involvement in genetic FTD within the GENFI cohort (2021) (26)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- Evidence for Allelic Heterogeneity in Familial Early-Onset Alzheimer's Disease (1991) (25)
- The Quality of Life Assessment Schedule (QOLAS): a new method for assessing quality of life (QOL) in dementia (2000) (25)
- Autopsy-confirmed familial early-onset Alzheimer disease caused by the l153V presenilin 1 mutation. (2001) (25)
- Diagnosis of early Alzheimer's disease. (1999) (25)
- BRAIN MUSCARINIC RECEPTORS IN ALZHEIMER'S AND PARKINSON'S DISEASES (1989) (25)
- Description of a simple test for CADASIL disease and determination of mutation frequencies in sporadic ischaemic stroke and dementia patients (2000) (25)
- Sporadic and familial dementia with ubiquitin-positive tau-negative inclusions: clinical features of one histopathological abnormality underlying frontotemporal lobar degeneration. (2005) (25)
- A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study (2017) (25)
- The Mini Mental State Examination (2005) (25)
- Dementia and driving: Results of a semi‐realistic simulator study (1995) (25)
- Do symptoms of memory impairment correspond to cognitive impairment: a cross sectional study of a clinical cohort (2006) (25)
- The prevalence of oligoclonal bands in the CSF of patients with primary neurodegenerative dementia (2004) (25)
- Provisional clinical and neuroradiological criteria for the diagnosis of Pick's disease (1998) (25)
- Scintigraphy with 123I-serum amyloid P component in Alzheimer disease. (1998) (24)
- White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study (2019) (24)
- THIORIDAZINE IS NOT SPECIFIC FOR LIMBIC DOPAMINE RECEPTORS (1982) (24)
- Neuropeptides in degenerative disease of the central nervous system (1982) (24)
- Diagnosis of Alzheimer's Disease: Report of an International Psychogeriatric Association Special Meeting Work Group Under the Cosponsorship of Alzheimer's Disease International, the European Federation of Neurological Societies, the World Health Organization, and the World Psychiatric Association (1997) (24)
- Familial and sporadic Alzheimer's disease (2001) (24)
- MOLECULAR PATHOLOGY OF ALZHEIMERS-DISEASE (1993) (23)
- EXTRAPYRAMIDAL SIGNS IN DEMENTIA OF ALZHEIMER TYPE (1989) (23)
- Differential Diagnosis of Frontotemporal Dementia: Pick’s Disease (1999) (23)
- TDP43 pathology in the brain, spinal cord, and dorsal root ganglia of a patient with FOSMN (2019) (23)
- Familial dementia lacking specific pathological features presenting with clinical features of corticobasal degeneration (1998) (23)
- Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort (2020) (23)
- Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations (1999) (23)
- Regional brain metabolite abnormalities in inherited prion disease and asymptomatic gene carriers demonstrated in vivo by quantitative proton magnetic resonance spectroscopy (2006) (23)
- A comparison of beta-amyloid deposition in the medial temporal lobe in sporadic Alzheimer's disease, Down's syndrome and normal elderly brains. (1996) (23)
- Seizures as an early symptom of autosomal dominant Alzheimer's disease (2019) (23)
- Artistic changes in Alzheimer's disease. (2006) (22)
- CONFIRMATION THAT THE APOLIPOPROTEIN E4 ALLELE IS ASSOCIATED WITH LATE-ONSET, FAMILIAL ALZHEIMERS-DISEASE (1993) (22)
- A novel technique for the quantitative assessment of apraxic deficits: application to individuals with mild cognitive impairment. (2007) (22)
- Neurochemical Studies in Dementia (1988) (21)
- Voxel-Based Morphometry in Tau-Positive and Tau-Negative Frontotemporal Lobar Degenerations (2004) (21)
- EFNS task force on molecular diagnosis of neurologic disorders Guidelines for the molecular diagnosis of inherited neurologic diseases First of two parts (2001) (21)
- Neuropsychological profiles of familial Alzheimer's disease associated with mutations in the presenilin 1 and amyloid precursor protein genes (2001) (21)
- Distinguishable effects of Presenilin-1 and APP717 mutations on amyloid plaque deposition (2001) (21)
- Cerebral microbleeds in familial Alzheimer's disease. (2012) (21)
- Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid? (2016) (21)
- Can we model a cognitive footprint of interventions and policies to help to meet the global challenge of dementia? (2015) (21)
- Resolving MRI abnormalities with progression of subacute sclerosing panencephalitis (2004) (20)
- The distribution and characterisation of thyrotrophin releasing hormone (TRH) in the human brain (1981) (20)
- Presymptomatic Generalized Brain Atrophy in Frontotemporal Dementia Caused by CHMP2B Mutation (2009) (20)
- Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid‐registered MRI (2003) (20)
- Automated Measurement of Hippocampal Atrophy Using Fluid-Registered Serial MRI in AD and Controls (2007) (20)
- Alzheimer's Disease and Other Disorders Associated With Dementia (2008) (19)
- Abnormal laughter-like vocalisations replacing speech in primary progressive aphasia (2009) (19)
- A novel A781V mutation in the CSF1R gene causes hereditary diffuse leucoencephalopathy with axonal spheroids☆ (2013) (19)
- Short TE Quantitative Proton Magnetic Resonance Spectroscopy in Variant Creutzfeldt-Jakob Disease (2006) (19)
- A correlative study on hippocampal cation shifts and amino acids and clinico-pathological data in Alzheimer's disease (1987) (18)
- No evidence that extended tracts of homozygosity are associated with Alzheimer's disease (2011) (18)
- Prion protein (PRNP) genotypes in frontotemporal lobar degeneration syndromes (2006) (17)
- Pathogenic presenilin 1 mutations (P436S & I143F) in early‐onset Alzheimer's disease in the UK (1999) (17)
- Central alveolar hypoventilation associated with paraneoplastic brain-stem encephalitis and anti-Hu antibodies (1994) (17)
- Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes (2015) (17)
- Slowing the progression of Alzheimer disease: monitoring progression. (1997) (16)
- Erratum to “Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial” [Rev. Neurol. 169 (10) (2013) 737–743] (2013) (16)
- Cerebral and cerebellar atrophy on serial magnetic resonance imaging in an initially symptom free subject at risk of familial prion disease (1997) (16)
- Non-Alzheimer dementias in young patients (1996) (16)
- Memory complaints and increased rates of brain atrophy: risk factors for mild cognitive impairment and Alzheimer's disease (2010) (16)
- A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group. (1996) (15)
- [Accepted Manuscript] Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study. (2017) (15)
- Fortnightly review : Alzheimer's disease (1993) (15)
- Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy (2004) (15)
- The Alien Limb (2004) (15)
- The association of gegenhalten in the upper limbs with dyspraxia. (1988) (14)
- Unravelling the disease process (2001) (14)
- Donepezil enhances understanding of degraded speech in Alzheimer's disease (2017) (14)
- The Neuro-Behavioural Syndrome of Brainstem Disease (2008) (14)
- Apolipoprotein E alleles but neither apolipoprotein B nor apolipoprotein AI/CIII alleles are associated with late onset, familial Alzheimer's disease (1995) (14)
- Olfactory impairment in posterior cortical atrophy (2013) (14)
- Cortical nicotinic receptors in Alzheimer's disease and Parkinson's disease. (1991) (14)
- Early cognitive decline in Creutzfeldt-Jakob disease associated with human growth hormone treatment (2003) (14)
- Dementia associated with haemochromatosis: a report of two cases (1997) (14)
- APOLIPOPROTEIN-E GENOTYPE AND ALZHEIMERS-DISEASE (1993) (14)
- Quantitative distribution of neurohypophysial hormones in human brain and spinal cord. (1983) (13)
- Management of neurological disorders: dementia. (1994) (13)
- Biological markers in mental disorders: post-mortem studies. (1984) (13)
- Cerebral achromatopsia as a presentation of Trousseau's syndrome. (1995) (13)
- HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q (2009) (13)
- Neurology: A Queen Square Textbook (2nd ed.) (2016) (13)
- Post-Mortem Neurochemical Changes in Alzheimer's Disease Compared With Normal Ageing (1986) (13)
- A cognitive chameleon: Lessons from a novel MAPT mutation case (2013) (13)
- Suspected early dementia (2011) (13)
- Binary reversals in primary progressive aphasia (2016) (13)
- The genetics of Alzheimer's disease. (1994) (13)
- The uncertain nosology of Hashimoto encephalopathy. (2003) (13)
- Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion (2012) (13)
- Protein Folding, Nucleation Phenomena and Delayed Neurodegeneration in Alzheimer's Disease (1996) (13)
- A case of sporadic Pick disease with onset at 27 years. (1999) (13)
- National survey to assess current practices in the diagnosis and management of young people with dementia (2002) (12)
- Neuronal loss in familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions (2003) (12)
- Education and training of European neurologists in dementia (2007) (12)
- Does Early‐Onset Alzheimer Disease Constitute a Distinct Subtype? The Contribution of Molecular Genetics (1995) (12)
- Pathogenic presenilin 1 mutations (P436S & I143F) in early-onset Alzheimer's disease in the UK. Mutations in brief no. 223. Online. (1999) (12)
- Symptoms of Memory Loss as Predictors of Cognitive Impairment?: The Use and Reliability of Memory Ratings in a Clinic Population (2007) (12)
- Effect of donepezil on transcranial magnetic stimulation parameters in Alzheimer's disease (2018) (11)
- Thalamic degeneration with negative prion protein immunostaining (2000) (11)
- Dementia and driving: European National Guidelines (2000) (11)
- EFNS task force on molecular diagnosis of neurologic disorders Guidelines for the molecular diagnosis of inherited neurologic diseases Second of two parts (2001) (11)
- Defining and describing the pre-dementia stages of familial Alzheimer's disease (2011) (11)
- Sensitivity of Diagnostic Criteria in Autopsy-Confirmed Patients with Behavioral Variant Frontotemporal Dementia (bvFTD): First Report of the International bvFTD Criteria Consortium (FTDC) (2011) (11)
- Pure progressive amnesia and the APPV717G mutation. (2009) (11)
- Designing for e-Health: Recurring Scenarios in Developing Grid-based Medical Imaging Systems (2006) (10)
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (vol 41, pg 1088, 2009) (2013) (10)
- Immunohistochemistry distinguishes between Pick's disease and corticobasal degeneration (2000) (10)
- Effectiveness of rivastigmine in Alzheimer's disease. Patients' view on quality of life should be assessed. (1999) (10)
- Alzheimer's disease and genetic testing. (1994) (10)
- A second family with familial AD and the V717L APP mutation has a later age at onset (2006) (10)
- Modelling the occurrence and pathology of Alzheimer's disease (1989) (10)
- Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer’s disease (2020) (10)
- Genetic characterization of a familial non-specific dementia originating in Jutland, Denmark (1993) (10)
- The Dementias 2 (2007) (10)
- Immunocytochemical confirmation of prion protein (1990) (10)
- Shunt responsive progressive supranuclear palsy? (2007) (9)
- Pick's Disease (2011) (9)
- Snouting, Pouting and Rooting (2001) (9)
- Catastrophe, Chaos and Alzheimer's Disease (1995) (9)
- Exome sequencing reveals a novel partial deletion in the progranulin gene causing primary progressive aphasia (2013) (9)
- Queen Square: A History of the National Hospital and its Institute of Neurology (2018) (9)
- FAMILIAL ALZHEIMERS-DISEASE (1992) (9)
- Alzheimer’s disease: towards therapeutic manipulation of the amyloid precursor protein and amyloid β-peptides (1997) (9)
- The Challenges of Developing a Collaborative Data and Compute Grid for Neurosciences (2006) (9)
- Alterations in brain opiate receptors in Parkinson's disease. (1979) (8)
- Knight’s move thinking? Mild cognitive impairment in a chess player (2005) (8)
- Clinical–anatomical correlation in a selective phonemic speech production impairment (2004) (8)
- An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels (2010) (8)
- FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration (2010) (8)
- CHCHD10 Pro34Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia. (2016) (8)
- Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study (2021) (8)
- The Cystatin-C gene is not linked to early onset familial Alzheimer's disease (1993) (8)
- Suspecting dementia: canaries, chameleons and zebras (2021) (8)
- Postmortem studies of peptides in Alzheimer's disease and Huntington's disease. (1986) (8)
- Amyloid deposition and cerebral glucose metabolism in mild cognitive impairment: A longitudinal 11C-PIB and 18F-FDG PET study (2007) (8)
- FOCAL CHANGES IN ALZHEIMER'S DISEASE AND CHOLINERGIC HYPOTHESIS (1983) (8)
- Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes (2021) (8)
- Zoster paresis with Horner’s syndrome (2003) (8)
- O4-05-08 Effects of A-beta immunotherapy (AN1792) on MRI measures of brain, ventricle and hippocampal volumes in Alzheimer's disease (2004) (7)
- Disease-related cortical thinning in presymptomatic granulin mutation carriers (2020) (7)
- Faculty Opinions recommendation of Spectrum of cognitive impairment in neurocysticercosis: differences according to disease phase. (2012) (7)
- Inspired by chance: valuing patients’ informal contributions to research (2020) (7)
- Neurofilament inclusion body disease (2003) (7)
- Beta A4 protein deposition in familial Alzheimer's disease with the mutation in codon 717 of the beta A4 amyloid precursor protein gene and sporadic Alzheimer's disease. (1993) (7)
- Alzheimer's disease. (1993) (7)
- Neuropeptides in Human Brain: Studies on Substance P, Cholecystokinin, Vasoactive Intestinal Polypeptide and Methionine-Enkephalin in Normal Human Brain and in Huntington Disease (1981) (7)
- Compulsive versifying after treatment of transient epileptic amnesia (2014) (7)
- Longitudinal (18F)AV-1451 PET imaging in a patient with frontotemporal dementia due to a Q351R MAPT mutation (2019) (7)
- Supporting clinical research in the NHS in England: the National Institute for Health Research Dementias and Neurodegenerative Diseases Research Network (2012) (7)
- Neurosarcoidosis presenting as benign intracranial hypertension. (1990) (6)
- Dissecting IWG-2 typical and atypical Alzheimer's disease: Insights from cerebrospinal fluid analysis (2015) (6)
- Medial medullary syndrome associated with patent foramen ovale in a weightlifter. (1996) (6)
- Seeing what Alzheimer saw—with magnetic resonance microscopy (2000) (6)
- Post-mortem neurochemistry of human brain. (1986) (6)
- Alzheimer's disease and neuroimaging (2001) (6)
- The Language of Neurology: Symptoms, Signs and Basic Investigations (2009) (6)
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference (2018) (6)
- Can Clinical Features Predict Tau Pathology in Patients with Behavioral Variant Frontotemporal Dementia (bvFTD)? (P05.101) (2013) (6)
- Amnesia, cerebral atrophy, and autoimmunity (vol 361, pg 1266, 2003) (2004) (6)
- CHCHD 10 Pro 34 Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia (2016) (6)
- Tonsil biopsy in the investigation of suspected variant Creutzfeldt-Jakob disease - A cohort study of 50 patients (2005) (6)
- Relationships between β-amyloid (Aβ) deposits and blood vessels in patients with sporadic and familial Alzheimer's disease (1996) (5)
- Imaging in dementia: Longitudinal studies using positron emission tomography (1992) (5)
- In vivo imaging of amyloid deposition and neuroinflammation in mild cognitive impairment with 11C-PIB and 11C-PK11195 pet (2008) (5)
- Parietal lobe deficits are a feature of frontotemporal lobar degeneration caused by a mutation in the progranulin gene (2007) (5)
- Early Implementation and Evaluation of StepUp for Dementia Research: An Australia-Wide Dementia Research Participation and Public Engagement Platform (2021) (5)
- Presymptomatic Alzheimer's disease in the Dominantly Inherited Alzheimer's Network (DIAN) (2012) (5)
- Peptides and neurological disease (1986) (5)
- Report of the European Working Group on Dementia Drug Guidelines Meeting--Brussels, November 1997. (1998) (5)
- Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. (1997) (5)
- The palmomental reflex: stop scratching around! (2016) (5)
- TETRAHYDROAMINOACRIDINE AND ALZHEIMER'S DISEASE (1987) (5)
- Heterogeneity in Familial Alzheimer’s Disease (1992) (4)
- Alzheimer’s Disease and Chromosome 21 (1989) (4)
- Central pontine and extrapontine myelinolysis presenting with parkinsonism in a patient with cystic fibrosis (1999) (4)
- Erratum: Early behavioural changes in familial Alzheimers disease in the Dominantly Inherited Alzheimer Network (Brain (2015) 138 (103645) (10.1093/brain/awv004)) (2015) (4)
- Focus on Dementia (2003) (4)
- Mere forgetfulness or early Alzheimer's disease? (2000) (4)
- Screening for the APP codon 670 671 mutations in Alzheimer's disease (1993) (4)
- Relationship between the distribution of microglial activation and amyloid deposition in Alzheimer's disease: An 11C-PK11195 and 11C-PIB PET study (2007) (4)
- Different patterns of cerebral atrophy in semantic dementia and Alzheimer's disease: A volumetric MRI study (2000) (4)
- CHOLECYSTOKININ CONTENT IN THE BASAL GANGLIA IN HUNTINGTONS-DISEASE - THE EXPRESSION OF CHOLECYSTOKININ IMMUNOREACTIVITY IN STRIATAL GRAFTS TO IBOTENIC ACID-LESIONED RAT STRIATUM (1985) (4)
- A novel prion protein variant in a patient with semantic dementia (2017) (4)
- Aphasic Binary Reversals in Patients With Neurological Disease as a Barrier to Clinical Decision Making. (2019) (4)
- A 38-year-old man with a 9 month history of neurological and cognitive impairment (2003) (4)
- Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease (2018) (4)
- TREM2 VARIANTS INCREASE RISK OF TYPICAL EARLY-ONSET ALZHEIMER'S DISEASE BUT NOT OF PRION OR FRONTOTEMPORAL DEMENTIA (2014) (4)
- Alzheimer's disease: the entity and its cause. (1989) (4)
- International Medical Workshop covering progressive supranuclear palsy, multiple system atrophy and cortico basal degeneration (2001) (4)
- Frontal lobe or `nonspecific' dementias are genetically heterogeneous (1995) (3)
- Bilateral thalamic pain secondary to bilateral thalamic infarcts relieved by a further unilateral ischaemic episode (1999) (3)
- 019 Profiles of white matter degeneration in frontotemporal dementia (2012) (3)
- Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis (2020) (3)
- "Prion dementia" (1993) (3)
- Open biopsy in patients with acute progressive neurologic decline and absence of mass lesion (2011) (3)
- Extrapyramidal signs in dementia of Alzheimer type. (1989) (3)
- Does registration of serial MRI improve diagnosis of dementia? (2010) (3)
- HIPPOCAMPAL CATION SHIFTS AND AMINO-ACIDS AND CLINICOPATHOLOGICAL DATA IN ALZHEIMERS-DISEASE (1987) (3)
- A Clinicopathologic Study of Movement Disorders in Frontotemporal Lobar Degeneration (2020) (3)
- PRION DEMENTIA . REPLY (1993) (3)
- Alzheimer's disease. (1992) (3)
- Cholecystokinin Content in the Basal Ganglia in Huntington's Disease (1985) (3)
- "Patients' choice". (2005) (3)
- DEVELOPING STANDARDS FOR RESEARCH REGISTERS: APPLYING LEARNING FROM THE U.K.’S NATIONAL ‘JOIN DEMENTIA RESEARCH’ SERVICE (2017) (3)
- Effectiveness of rivastigmine in Alzheimer's disease (multiple letters) [3] (1999) (3)
- Psychiatric symptoms in patients with focal cortical degeneration. (1994) (3)
- Recent advances in the understanding of dementia. (1988) (3)
- Stability of pro-opiocortin-related peptides in post-mortem mouse brain tissue. (1982) (3)
- Genetic risk factors for posterior cortical atrophy (2015) (3)
- LONGITUDINAL BIOMARKER CHANGES IN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE FROM THE DIAN STUDY (2017) (2)
- DEMENTIA (1982) (2)
- Relationships between beta-amyloid (A beta) deposits and blood vessels in patients with sporadic and familial Alzheimer's disease. (1996) (2)
- Faculty Opinions recommendation of Novel CSF biomarkers for frontotemporal lobar degenerations. (2011) (2)
- The neuroimaging phenotype of frontotemporal dementia with the C9ORF72 hexanucletoide repeat expansion (2012) (2)
- The cultural context of visual hallucinations (2008) (2)
- The undiscovered syndrome: Macdonald Critchley’s case of semantic dementia (2014) (2)
- How dementia and neurodegenerative disease clinical research networks have enhanced research delivery in England (2014) (2)
- IMPAIRED DEFAULT NETWORK FUNCTIONAL CONNECTIVITY IN DIAN (2014) (2)
- Neuropsychological disorders, dementia, and behavioural neurology (2001) (2)
- Aging of the Brain and Alzheimer's Disease. (Progress in Brain Research Vol 70.) (1988) (2)
- Correcting brain volumes for total intracranial volume: Applications in serial studies of Alzheimer's disease (2004) (2)
- Quantitative Magnetization Transfer Imaging in Alzheimer (2007) (2)
- Early diagnosis of dementia (1999) (2)
- The Dementia UK Ecosystem: a call to action (2021) (2)
- Designing for e-Health (2006) (2)
- Patterns of Cerebral Metabolism in Degenerative Dementia (1990) (2)
- Early cognitive decline in Creutzfeldt-Jakob disease occurring in recipients of pituitary-derived human growth hormone (2002) (2)
- Lessons in familial Alzheimer’s disease (2001) (2)
- Functional morphology during normal and pathological ageing with emphasis on peptidergic transmission (1987) (2)
- Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum. Tonsil biopsy helps diagnose new variant Creutzfeldt-Jakob disease. (1998) (2)
- Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2018) (2)
- Future diagnosis and management of Alzheimer’s disease (2006) (2)
- BSE and Human Disease (1996) (2)
- Correction: Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease (2011) (2)
- GENFI - The GENetic Frontotemporal dementia Initiative (2012) (2)
- The Active Brains Digital Intervention to Reduce Cognitive Decline in Older Adults: Protocol for a Feasibility Randomized Controlled Trial (2020) (2)
- Clinical and Pathologic Features of Chromosome 21‐Linked Familial Alzheimer's Disease (1991) (2)
- Genetic Variability and Alzheimer’s Disease (1994) (2)
- Potassium channel antibody associated encephalitis: A potentially treatable non-paraneoplastic limbic encephalitis (2004) (2)
- S3-03-03 Serial magnetic resonance imaging as an outcome measure in dementia (2004) (1)
- Prevalence and growth of cerebral microhemorrhages in autosomal dominant Alzheimer's disease (2013) (1)
- REGIONAL VARIABILITY OF IMAGING BIOMARKERS IN DIAN (2014) (1)
- Prion dementia. (1993) (1)
- Automated method using iterative principal component analysis for detecting brain atrophy rates from sequential MRI in persons with Alzheimer's disease (2004) (1)
- Dementia recognition, diagnosis, and treatment in the UK, 1997–2017: a change-point analysis (2019) (1)
- HARNESSING CONSUMER TECHNOLOGIES AND CLINICAL DATA TO IMPROVE RECRUITMENT TO CLINICAL STUDIES: A REVIEW OF THE FIRST 12 MONTHS OF THE JOIN DEMENTIA RESEARCH SERVICE IN THE UNITED KINGDOM (2016) (1)
- NEUROPEPTIDES IN THE AGING BRAIN (1983) (1)
- Apolipoprotein E genotyping in Alzheimer's disease. The UK Alzheimer's Disease Genetic consortium. (1996) (1)
- Early and late onset types of Alzheimer's disease (1984) (1)
- Alzheimer's disease and genetic testing. (1994) (1)
- Treatments for Alzheimer's disease. (1995) (1)
- Mapping the evolution of regional atrophy of regional atrophy in Alzheimer's disease using fluid registered MRI (2002) (1)
- The Language of Neurology (2016) (1)
- TRANSMITTER DEFICITS IN ALZHEIMERS-DISEASE - CRITIQUE (1985) (1)
- How to Write a Case Report (2012) (1)
- Presymptomatic focal atrophy precedes speech production impairment in familial frontotemporal lobar degeneration (2004) (1)
- NEUROPEPTIDE CHANGES IN ALZHEIMERʼS DISEASE (1984) (1)
- unusual cause . Acquired Brown ' s syndrome : an (1)
- Temporally ungraded retrograde amnesia in autoimmune encephalitis associated with antibodies to voltage-gated potassium channels (2007) (1)
- POD07 Tinnitus and hyperacusis in semantic dementia (2010) (1)
- Genetic risk factors for posterior cortical atrophy may be distinct from late-onset Alzheimer's disease (2012) (1)
- LONGITUDINAL CHANGE IN CSF BIOMARKERS IN DIAN (2014) (1)
- Ascending Systems in Alzheimer’s Disease (1985) (1)
- Neuropsychological profiles of familial Alzheimer's disease associated with mutation in the presenilin 1 gene (2000) (1)
- Can the physician predict the neuropathologist? (2001) (1)
- Comparison of digital platforms for participant recruitment in dementia research: Lessons and future directions from a global collaborative (2020) (1)
- Subject Index Vol. 17, 2004 (2004) (1)
- Association between human herpesvirus infections and dementia or mild cognitive impairment: a systematic review protocol (2017) (1)
- Correlation of regional cerebral amyloid load in Alzheimer's disease, measured with [11C]-PIB pet using spectral analysis and tissue uptake ratios, with Performance on recognition memory tests (2005) (1)
- Comparison of local grey matter volume in familial and sporadic Alzheimer's disease (2013) (1)
- Progressive Aphasia and Other Focal Syndromes (1994) (1)
- P2-120 Amyloid deposition and cerebral glucose metabolism in mild cognitive impairment : A longitudinal 11C-PIB and 18F-FDG PET study (2006) (1)
- Resting state functional connectivity in autosomal dominant and sporadic Alzheimer’s disease (2013) (1)
- Nasu-Hakola disease: Clinical manifestations of a novel mutation of TREM2 gene (2004) (1)
- Jargon language in frontotemporal lobar degeneration (2007) (1)
- The CBI‐R detects early behavioural impairment in genetic frontotemporal dementia (2022) (1)
- Vietnam Veterans in the General Hospital (1985) (1)
- MRI findings in an individual at risk for familial Alzheimer's disease. (1993) (1)
- Faculty Opinions recommendation of Tau positron emission tomographic imaging in aging and early Alzheimer disease. (2016) (1)
- Molecular nexopathies: a new paradigm of neurodegenerative (2013) (1)
- The relationship between amyloid load, microglial activation, and cognition in Alzheimer’s disease: PET findings (2005) (1)
- The cognitive footprint of medication: A review of cognitive assessments in clinical trials (2020) (1)
- Amyloid deposition and cerebral glucose metabolism in Alzheimer's disease: A longitudinal 11C-PIB and 18F-FDG PET study (2007) (1)
- Risus Sardonicus After Thalamic Haemorrhage (2004) (1)
- Incidence, morbidity, mortality and disparities in dementia: A population linked electronic health records study of 4.3 million individuals (2022) (1)
- Neuropeptides in Human Aging and Dementia (1985) (1)
- Teaching NeuroImages: Nonfluent variant primary progressive aphasia (2016) (1)
- A national open‐access research registry to improve recruitment to clinical studies (2021) (1)
- PROBING FTD GENETICS WITH NEXT-GENERATION SEQUENCING (2016) (1)
- Oxygen metabolism in the degenerative dementias (1990) (1)
- The neuroimaging phenotype of frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion (2012) (1)
- Olfactory threshold inParkinson's disease (1987) (1)
- Phenotypic variations in a familiar prion disease characterised by a 144 base pair insertion in the Prion protein gene (2000) (1)
- GeoSPM: Geostatistical parametric mapping for medicine (2022) (1)
- Reply: Functional cognitive disorder: dementia's blind spot. (2021) (1)
- Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic (2018) (1)
- Frontotemporal lobar degeneration with FUS-positive inclusions (2010) (1)
- Fluid registration of serial MRI: Identifying regional changes in Alzheimer's disease (2004) (1)
- International Efforts to Improve Alzheimer Disease Treatment (1995) (1)
- Cerebellar pathology in sporadic and familial Alzheimer's disease: A morphometric investigation (1997) (1)
- PRESYMPTOMATIC DEFICITS IN INDIVIDUALS AT RISK OF FAMILIAL ALZHEIMERS-DISEASE - A POSITRON EMISSION TOMOGRAPHY STUDY (1994) (1)
- ENCOURAGING PUBLIC PARTICIPATION IN DEMENTIA RESEARCH: ANALYSIS OF TAKE-UP AND COSTS FOLLOWING MAIL OUT TO 10,000 PATIENTS WITHIN GENERAL PRACTICE (2017) (1)
- Supporting clinical research in the NHS in England: the National Institute for Health Research Dementias and Neurodegenerative Diseases Research Network (2012) (1)
- Immune-related genetic enrichment in frontotemporal dementia (2017) (1)
- Prevalence and growth of cerebral microhemorrhages in autosomal dominant Alzheimer's disease (2013) (1)
- Familial Alzheimer's disease with an APP717 point mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology (1992) (1)
- Vascular and other dementias (2003) (1)
- Observations on the human rejection behaviour syndrome: Denny–Brown revisited (2004) (1)
- Comprar Neurology. A Queen Square Textbook 2nd Ed. | C. Clarke | 9781118486177 | Wiley (2016) (1)
- Cortical muscarinic receptors in demented patients with Alzheimer's disease or Parkinson's disease. (1989) (1)
- FROM THE WHO RESEARCH PRIORITIES AND RESEARCH PORTFOLIO ANALYSIS TO THE IDENTIFICATION OF RESEARCH GAPS TO REDUCE THE GLOBAL BURDEN OF DEMENTIA (2016) (1)
- Whole brain atrophy rates in cognitively normal persons at genetic risk for Alzheimer's disease (2002) (1)
- Determinants of survival in autopsy-confirmed patients with behavioral variant frontotemporal dementia (bvFTD): Second Report of the international bvFTD criteria consortium (FTDC) (2011) (1)
- Recommendations for the diagnosis and treatment of Alzheimer's disease and other disorders associated with dementia: The EFNS guidelines (2008) (1)
- A NEUROIMAGING STUDY OF INDIVIDUALS WITH APP MUTATIONS (1994) (1)
- Solitary intracranial plasmacytoma presenting as lateral rectus palsy: Report of a case and review of neuro-ophthalmic manifestations of plasmacytoma (1990) (1)
- Are early atrophy patterns in autosomal dominant familial Alzheimer's disease gene-dependent? (2013) (1)
- MRI to measure progression to AD and in AD (2004) (1)
- Resting state functional connectivity in autosomal dominant and sporadic Alzheimer's disease (2013) (1)
- Co-existing Alzheimer's disease and diffuse Lewy body disease mimicking Pick's disease (2005) (0)
- 9 International working group on harmonization of dementia drug guidelines (1996) (0)
- Assessment and investigation of the cognitively impaired adult (2016) (0)
- IS CHROMOSOME-21 IMPORTANT IN THE DEVELOPMENT OF AUTOIMMUNE THYROID-DISEASE (1991) (0)
- Reply from the authors [10] (2006) (0)
- P2-032: An unusual, APPV717G-associated familial Alzheimer's disease phenotype: Neuropsychological and radiological data (2008) (0)
- The ABCs of neurodegenerative dementias (2003) (0)
- THE EVOLUTION OF FRONTOTEMPORAL DEMENTIA DUE TO THE MAPT MUTATION: A SEVENTEEN YEAR NATURAL HISTORY STUDY (2013) (0)
- P2-182: Gelastic dementia: Laughter replacing speech in frontotemporal lobar degeneration (2008) (0)
- Cognitive composites for genetic frontotemporal dementia: GENFI-Cog (2022) (0)
- Dementia and driving: European national guidelines. EFNS Scientist Panel on Dementia. (2000) (0)
- Alien handsign inassociation withAlzheimer's histopathology (1993) (0)
- Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections (2018) (0)
- SETTING THE AGENDA: PREVENTION STUDIES FOR VASCULAR CONTRIBUTIONS TO DEMENTIA (2016) (0)
- LONGITUDINAL ATROPHY IN AUTOSOMAL DOMINANT AD AND SPORADIC AD: LESSONS FROM DIAN (2016) (0)
- Do rates of cerebral atrophy in Alzheimer's disease accelerate? (2002) (0)
- Suspected familial dementia with unexpected neuropathological findings (2006) (0)
- LONGITUDINAL RATES OF ATROPHY IN FAMILIAL ALZHEIMER'S DISEASE (2014) (0)
- Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion (2012) (0)
- Headache and central pain (2002) (0)
- MR spectroscopy demonstrates presymptomatic changes in familial Alzheimer’s disease (2005) (0)
- CHARACTERISING PRESYMPTOMATIC ATROPHY PATTERNS THROUGH MULTIVARIATE MACHINE LEARNING (2017) (0)
- Developmental regulation of tau splicing and phosphorylation is conserved in iPSC-neurons and disrupted by the 10+16 intronic mutation in MAPT (2016) (0)
- Detailed structural analysis of the hypothalamus in behavioral variant frontotemporal dementia (2015) (0)
- Picturing atrophy patterns of Progressive Supranuclear Palsy (PSP) in vivo using fluid registered MRI (2002) (0)
- Plasma phospho‐tau in familial Alzheimer’s disease (2020) (0)
- Plasma and Cerebrospinal Fluid Markers in the DIAN Study of Autosomal-Dominant Alzheimer’s Disease (2011) (0)
- The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort (2021) (0)
- A cross‐sectional study of memory and executive functions in patients with sporadic inclusion body myositis (2021) (0)
- P4-087 Familial Alzheimer's disease and cerebral haemorrhage: a second family with the flemish APP ALA692GLY mutation (2004) (0)
- DEMENTIAS PORTFOLIO DEVELOPMENT ACTIVITIES: UNITING AND SUPPORTING THE RESEARCH COMMUNITY TO INCREASE RESEARCH INCOME (2017) (0)
- Duplications of APP—but not PRNP—are a significant cause of early-onset dementia in a large UK referral series (2009) (0)
- One hundred years of shared interest (2020) (0)
- 1130 White matter lesions in familial Alzheimer's disease: evidence for influence of mutation position on amyloid angiopathy? (2012) (0)
- P.01 Characterising the clinical phenotype of familial Alzheimer's disease (FAD) (2011) (0)
- Differences in atrophy on MRI and voxel-based morphometry in progressive supranuclear palsy (PSP) and Parkinson's disease (PD) (2004) (0)
- IC-P3-162: Generalised brain atrophy predates symptom onset in frontotemporal dementia caused by CHMP2B mutation (2008) (0)
- DEMENTIA: THIRTY YEARS BACK AND FORTH (2017) (0)
- Volumetry of the cerebellum and its subregions in genetic frontotemporal dementia (2015) (0)
- Main title Longitudinal [18F]AV-1451 PET imaging in a patient with frontotemporal dementia due to a Q351R MAPT mutation. Authors (2019) (0)
- Explorer The Edinburgh Consensus : Preparing for the advent of disease-modifying therapies for Alzheimer ' s disease (2017) (0)
- O4-06-02 TDP-43 AND BETA-AMYLOID PRECURSOR PROTEIN PROCESSING PRODUCTS IN CEREBROSPINAL FLUID OF PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL LOBAR DEGENERATION (0)
- Abnormalities of fronto-striato-thalamic tract structure and effective connectivity in familial Alzheimer's disease (2013) (0)
- Premorbid brain volume and dementia - Reply (2001) (0)
- Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer’s disease (2020) (0)
- CHARACTERISING PRESYMPTOMATIC ATROPHY PATTERNS THROUGH MULTIVARIATE MACHINE LEARNING (2017) (0)
- Workshop 1: Differential Diagnosis (1997) (0)
- Relationship between amyloid deposition and atrophy rates in Alzheimer's disease using C-11-PIB radiotracer (2006) (0)
- MEASURING CORTICAL MEAN DIFFUSIVITY TO ASSESS EARLY MICROSTRUCTURAL CORTICAL CHANGE IN PRESYMPTOMATIC AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE (2019) (0)
- Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study (2012) (0)
- Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales (2018) (0)
- O4-06-02 The relationship between specific histopathology and patterns of atrophy on MRI in frontotemporal lobar degeneration (2004) (0)
- O2-06-01: A powerful, genome-wide association scan for susceptibility genes for late-onset Alzheimer's disease (2008) (0)
- Rates of brain and hippocampal atrophy in presymptomatic familial Alzheimer's disease: Acceleration and mutation effects (2012) (0)
- The Spectrum of FUS-Positive Pathology in Frontotemporal Lobar Degenerations (2010) (0)
- 23 Dementia: thirty years back and forth (2017) (0)
- 0804 PRION-1 TRIAL: Therapies for human prion disease (ISRCTN06722585) (2005) (0)
- O3-06-03: Profiles of longitudinal brain atrophy in semantic dementia (2008) (0)
- P2-307: CPHPC depletes serum amyloid P component from the cerebrospinal fluid in Alzheimer's disease (2008) (0)
- A voxel-based morphometry study of volumetric MRI in familial Alzheimer's disease (2012) (0)
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease (2019) (0)
- PATHOLOGICAL CORRELATES OF WHITE MATTER HYPERINTENSITIES ON CADAVERIC MRI IN PROGRANULIN-ASSOCIATED FRONTOTEMPORAL DEMENTIA (2017) (0)
- LONGITUDINAL CLINICAL AND BIOMARKER CHANGES IN DOMINANTLY INHERITED ALZHEIMER'S DISEASE: THE DOMINANTLY INHERITED ALZHEIMER NETWORK (2016) (0)
- NEUROIMAGING AND HETEROGENEITY IN FAMILIAL ALZHEIMER'S DISEASE (2017) (0)
- Diagnosis af Alzheimer's disease. Workshop 1: Differential diagnosis (1997) (0)
- Short-term spatial memory is impaired in early Alzheimer's disease but not in temporal variant frontotemporal lobar degeneration (2009) (0)
- Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study (2012) (0)
- PRION PROTEIN GENE ANALYSIS IN PRESENILE DEMENTING AND ATAXIC ILLNESSES (1990) (0)
- Unusual dementias. Introduction. (1992) (0)
- Degenerative diseases. (1995) (0)
- Selective preservation of visual motion perception in posterior cortical degeneration (2009) (0)
- Familial Alzheimer's disease and Lewy body pathology (1999) (0)
- DIAN OVERVIEW AND COHORT CHARACTERISTICS (2014) (0)
- Clinical spectrum of familial Alzheimer's disease in 100 cases (2012) (0)
- A LONGITUDINAL MORPHOMETRIC STUDY OF FAMILIAL ALZHEIMER’S DISEASE: RESULTS FROM DIAN (2016) (0)
- USING FLORBETAPIR PET TO INCREASE DIAGNOSTIC CERTAINTY IN ATYPICAL DEMENTIAS (2015) (0)
- Brain biopsy in dementia: A review of 90 consecutive cases from Queen Square (2005) (0)
- MRI as a longitudinal measure in MCI and AD (2000) (0)
- Human stem cell models of frontotemporal dementia caused by a non-coding hexanucleotide repeat expansion in C9ORF72 (2013) (0)
- Faculty Opinions recommendation of Isolated theory of mind deficits and risk for frontotemporal dementia: a longitudinal pilot study. (2012) (0)
- Alzheimer ' s histopathology . Alien hand sign in association with (0)
- MRI results from the DIAN study The pattern of atrophy in familial Alzheimer disease : Volumetric (0)
- Faculty Opinions recommendation of Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. (2011) (0)
- The independent effects of white matter hyperintensity volume and cerebrospinal fluid amyloid levels on brain atrophy (2011) (0)
- Behavioural neurology—a practical approach. Howard S. Kirshner. Clinical neurology and neurosurgery monographs, vol. 7. Churchill Livingstone, Edinburgh, 1986 (1986) (0)
- Better together for better dementia research and care. (2016) (0)
- Elucidating the genetic factors of Alzheimer's disease (1998) (0)
- Preservation of verb naming in severe Alzheimer’s Disease (2002) (0)
- Can We Identify Early Alzheimer ' s Disease ? (2005) (0)
- Dementia in dementia with Lewy bodies may not be attributable to Alzheimer pathology (2004) (0)
- Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study (2012) (0)
- A prospective clinicopathological study of familial dementias: A neuropathological review of 56 cases. (1997) (0)
- The independent effects of white matter hyperintensity volume and cerebrospinal fluid amyloid levels on brain atrophy (2011) (0)
- Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study (2012) (0)
- Chromosome 3 related frontotemporal dementia (2003) (0)
- Voltage-gated potassium channel antibody associated limbic encephalitis is relatively common, potentially treatable, and usually nonaraneoplastic (2003) (0)
- Long-Term Outcome of Clozapine Use for Psychosis in Parkinsonian Patients (2004) (0)
- Abstracts of the British Neuropsychological Society Spring 2008 Meeting 8th–9th April 2008 (2008) (0)
- Psychologically determined disorders (2009) (0)
- Dementia: Trial Design and Experience with Large Multicentre Trials (2001) (0)
- Tracking progression with serial MRI in the language variants of frontotemporal lobar degeneration (2011) (0)
- LONGITUDINAL RESEARCH INTO ALZHEIMER'S DISEASE, FRONTO–TEMPORAL DEMENTIA AND OTHER DEMENTIAS (2013) (0)
- FORTNIGHTLY REVIEW - ALZHEIMERS-DISEASE (1993) (0)
- Alzheimer's disease and other degenerative dementias (2001) (0)
- Cognitive footprint (2018) (0)
- Mad cows and demented people. (1996) (0)
- Subject Index Vol. 19, 2005 (2005) (0)
- FRONTO-SUBCORTICAL HYPOPERFUSION IN PRESYMPTOMATIC FTD IS ASSOCIATED WITH BEHAVIORAL MEASURES, BUT NOT COGNITIVE DEFICITS: THE GENFI STUDY (2017) (0)
- Recognition of emotions in faces, voices and music in frontotemporal lobar degeneration (2007) (0)
- Deconstructing language disintegration: Primary progressive aphasias have specific tractographic signatures (2011) (0)
- In vivo mapping of the onset and progression of neurodegeneration in frontotemporal lobar degeneration (2002) (0)
- Preface: Lars Gustafson, Lund; Arne Brun, Lund (1999) (0)
- THEMES AND VARIATIONS IN PPA: A CLINICAL AND NEUROBIOLOGICAL ANALYSIS OF THE UCL COHORT (2017) (0)
- Preface: Lars Gustafson, Lund; Arne Brun, Lund (1999) (0)
- White matter lesions in familial Alzheimer's disease: evidence for influence of mutation position on amyloid angiopathy? (2011) (0)
- Rates of brain and hippocampal atrophy in presymptomatic familial Alzheimer's disease: Acceleration and mutation effects (2012) (0)
- Dominantly Inherited Alzheimer Network (DIAN): History genetic and pathology overview and update (2011) (0)
- Cerebral atrophy variation over short time intervals in transient ischaemic attack (TIA) patients (2003) (0)
- IMPLEMENTING POLICY AND SYSTEM CHANGE TO MAKE OFFERING CLINICAL RESEARCH A STANDARD PART OF DEMENTIA CARE PATHWAYS IN THE UNITED KINGDOM (2018) (0)
- Dementia: A Clinical Approach (1986) (0)
- The prevalence of oligoclonal bands in the cerebrospinal fluid of patients with primary neurodegenerative dementia (2003) (0)
- BOOK REVIEWS (1991) (0)
- Dissociating volume and intensity differences in familial Alzheimer's disease (2013) (0)
- Contents, Vol 36, 1996 (1990) (0)
- IC-P-192 EFFECTS OFAMYLOID-B DEPOSITION ON MITOCHONDRIAL COMPLEX I ACTIVITY IN BRAIN: A PET STUDY IN AGED MONKEYS (2014) (0)
- Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis (2019) (0)
- Nonlinear registration of T1 MR imaging helps to support a diagnosis of a MAPT mutation when the phenotype is atypical (2013) (0)
- Abnormalities of fronto-striato-thalamic tract structure and effective connectivity in familial Alzheimer's disease (2013) (0)
- Microglial activation and amyloid deposition on mild cognitive impairment: An C-11-PK11195 and C-11-PIB PET study (2008) (0)
- Dementia and music: fMRI signatures of molecular nexopathies (2015) (0)
- Network Structures and Dynamics Of Early Dementia Events Recorded in Primary Care Electronic Health Records (2019) (0)
- disease confirmed at necropsy . in a pedigree with familial Alzheimer ' s presymptomatic neuropsychological features with familial Alzheimer ' s disease : The earliest cognitive change in a person (0)
- The clinical and behavioural correlates of right temporal lobe atrophy (2003) (0)
- 06 Early subcortical amyloid deposition in familial Alzheimer's disease is accompanied by changes in tissue volume and diffusivity (2011) (0)
- Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer’s disease (2017) (0)
- A voxel-based morphometry study of volumetric MRI in familial Alzheimer's disease (2012) (0)
- Patterns of cortical thickness in pathologically-confirmed typical and atypical Alzheimer's disease (2011) (0)
- Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease (2018) (0)
- Movement disorders: A neuropsychiatric approach. J. P. Lohr and A. A. Wisniewski. Wiley, Chichester, 1988. No. of pages: 387. Price: £39.50 (US $82.50) (1989) (0)
- Sporadic fatal insomnia (sFI): Report of a case (2000) (0)
- Rates or global atrophy and sensitivity and specificity in AD (2001) (0)
- Neurofilament light chain: a biomarker for disease onset and survival in genetic frontotemporal dementia (2016) (0)
- The diagnosis of Alzheimer disease: Facts and fallacies - Neuroimaging in Alzheimer disease: Prion diseases (1998) (0)
- THE MOTOR DISORDER OF ALZHEIMERS DEMENTIA - CLINICAL AND PET STUDIES (1990) (0)
- The neuropathological classification of familial frontotemporal dementia. (2001) (0)
- Nonlinear registration of T1 MR imaging helps to support a diagnosis of a MAPT mutation when the phenotype is atypical (2013) (0)
- Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2018) (0)
- EFFECT OF DONEPEZIL ON TRANSCRANIAL MAGNETIC STIMULATION PARAMETERS IN ALZHEIMER’S DISEASE (2017) (0)
- Using florbetapir F18 PET to validate CSF cut-points and increase diagnostic certainty in atypical dementias (2015) (0)
- A novel presenilin 1 deletion (exon 6 Delta 166) associated with early onset familial Alzheimer's disease (2007) (0)
- Familial Alzheimer's disease: How early does medial temporal lobe atrophy occur? (2002) (0)
- DONEPEZIL MODULATES PERCEPTUAL LEARNING IN ALZHEIMER’S DISEASE (2017) (0)
- SERUM NEUROFILAMENT LIGHT CONCENTRATION AND PROGRESSION IN FAMILIAL ALZHEIMER’S DISEASE (2018) (0)
- Author and Subject Index (1998) (0)
- Author and Subject Index (1998) (0)
- Plasma catecholamines and the acute effects of oral L-dopa in Parkinsonian patients [proceedings]. (1979) (0)
- COMPULSIVE VERSIFYING IN TRANSIENT EPILEPTIC AMNESIA (2014) (0)
- Grey matter differences in genetic frontotemporal dementia: Results from the genfi study (2015) (0)
- ABNORMAL SOUND AND MUSIC REWARD PROCESSING IN DEMENTIA: A BEHAVIOURAL AND NEUROANATOMICAL ANALYSIS (2015) (0)
- Probing FTD genetics with a next-generation sequencing gene panel (2016) (0)
- Global drug development in dementia (1998) (0)
- UvA-DARE (Digital Academic Repository) Receptive prosody in nonfluent primary progressive aphasias (2017) (0)
- Genetic influences on amyloid angiopathy and white matter pathology in familial Alzheimer's disease: A comparison of app and PSEN1 mutations (2015) (0)
- IC-P3-190: An unusual, APPV717G-associated familial Alzheimer's disease phenotype: Neuropsychological and radiological data (2008) (0)
- Neurofilament inclusion body disease (NIBD) - A new form of dementia (2004) (0)
- Dementia, 4th Edition (2010) (0)
- LETTER TO THE EDITOR CHCHD10 Pro34Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia (2016) (0)
- Active Brains: Protocol for a Feasibility Randomised Control Trial of a Digital Intervention to Reduce Cognitive Decline in Older Adults (2020) (0)
- Correlations between the distribution of microglial activation and amyloid plaque load in Alzheimer’s disease: An 11C-PK11195 and 11C-PIB PET study (2005) (0)
- P2-294 Magnetization transfer ratio in Alzheimer’s disease: Comparison with volumetric measurements (2006) (0)
- Contents Vol. 19, 2005 (2005) (0)
- Subject Index Vol. 36, 1996 (1996) (0)
- Contents Vol. 17, 2004 (2004) (0)
- NEUROPSYCHOLOGY, DEMENTIA AND AGING - OVERVIEW (1988) (0)
- Dissociating volume and intensity differences in familial Alzheimer's disease (2013) (0)
- DOPAMINE D-1-RECEPTORS AND D-2-RECEPTORS IN HUNTINGTONS-DISEASE (1983) (0)
- LONG-TERM FORGETTING IN PRECLINICAL FAMILIAL ALZHEIMER'S DISEASE (2016) (0)
- Survival in alzheimer disease. Authors' reply (2005) (0)
- Human stem cell models of tauopathy (2016) (0)
- A 2020 vision for JNNP (2019) (0)
- Pathologic Heterogeneity of Alzheimer's Disease-Reply (1988) (0)
- Comprar The Dementias 2 | John H. Growdon | 9780750675420 | Butterworth Heinemann (2007) (0)
- Distribution and molecular forms of bombesin and glucagon-like immunoreactivities in human brain (1983) (0)
- Comparison of local grey matter volume in familial and sporadic Alzheimer's disease (2013) (0)
- HABITUAL EXERCISE LEVELS ARE ASSOCIATED WITH CEREBRAL AMYLOID LOAD IN PRE-SYMPTOMATIC AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE (2017) (0)
- HOW TO DO IT (2005) (0)
- Picturing the atrophy patterns of progressive supranuclear palsy and multiple system atrophy in vivo using fluid registered MRI (2003) (0)
- Harmonization and innovation of cognitive, behavioural and functional assessment in neurodegenerative dementias (2015) (0)
- Are early atrophy patterns in autosomal dominant familial Alzheimer's disease gene-dependent? (2013) (0)
- What can the degenerative dementias tell us about the modular organisation of the cerebral cortex (2008) (0)
- Olfactory function in posterior cortical atrophy (2012) (0)
- The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease (2017) (0)
- CHOLINERGIC MARKERS IN ALZHEIMERS-DISEASE AND PARKINSONS-DISEASE (1990) (0)
- A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study (2018) (0)
- Treatment and Management - a Major Challenge (2012) (0)
- P3-375 Correlation between patterns of atrophy and psychomotor task performance in early huntington's disease (2004) (0)
- SAMPLE SIZE ESTIMATES FOR SECONDARY PREVENTION STUDIES USING REGIONAL ATROPHY RATES (2018) (0)
- Longitudinal clinical, radiological and neuropsychological profile of an at-risk family member from a kindred with progranulin-associated frontotemporal lobar degeneration (2007) (0)
- Neuroanatomical study of olfactory function in posterior cortical atrophy (2013) (0)
- O3-06-05 Amyloid deposition and cerebral glucose metabolism in Alzheimer’s disease: A longitudinal 11C-PIB and 18F-FDG PET study (2006) (0)
- IN56-TH-01 Measuring and monitoring the degenerative dementias (2009) (0)
- Amyloid load in mild cognitive impairment compared to Alzheimer patients and normal subjects: An 11C-PIB PET study (2005) (0)
- Can primary care electronic health records facilitate the prediction of early cognitive decline associated with dementia: a systematic literature review (2017) (0)
- 0781 Delusions and hallucinations in dementia with Lewy bodies: Worsening with memantine (2005) (0)
- SAMPLE SIZE ESTIMATES FOR SECONDARY PREVENTION STUDIES USING REGIONAL ATROPHY RATES (2018) (0)
- UPDATE Functional cognitive disorder: dementia’s blind spot (2020) (0)
- An Anatomopathological Classification of Frontotemporal Lobar Degeneration (2010) (0)
- P2-183: Generalised brain atrophy predates symptom onset in frontotemporal dementia caused by CHMP2B mutation (2008) (0)
- GENETIC-LINKAGE ANALYSIS IN LATE-ONSET ALZHEIMERS-DISEASE (1993) (0)
- Deconstructing language disintegration: Primary progressive aphasias have specific tractographic signatures (2011) (0)
- Using induced pluripotent stem cells to model C9orf72-linked Frontotemporal Dementia (2016) (0)
- Registration of serial magnetic resonance imaging scans in Alzheimer's disease: Sensitivity and specificity of rates of atrophy (2000) (0)
- Recipes no longer a piece of cake (2016) (0)
- P1-287: Proton spectroscopy in Alzheimer's disease: A longitudinal multiple time point study (2008) (0)
- Plasma catecholamines and the acute effects of oral L-dopa by Parkinsonian patients (1979) (0)
- Grey matter differences in genetic frontotemporal dementia: Results from the genfi study (2015) (0)
- 125 CANDID: A unique new service providing information & support (1996) (0)
- Progress towards a neuronal cell model of the tauopathies (2010) (0)
- Comprehensive neurology. Edited by Roger N. Rosenberg. Raven Press, New York, 1991. No. of pages: 885. price: $275 (1993) (0)
- The frontotemporal lobar degenerations as 'molecular nexopathies' (2012) (0)
- Rapid communication Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration (2009) (0)
- Detailed structural analysis of the hypothalamus in behavioral variant frontotemporal dementia (2015) (0)
- CATASTROPHE, CHAOS AND ALZHEIMERS-DISEASE - THE WILLIAMS,F.E LECTURE (1995) (0)
- Early diagnosis of Alzheimer's disease and related dementia (DIADEM) - A research network funded by the European Union (2002) (0)
- Book Review: Biochemical Neurology (1983) (0)
- ABNORMAL PAIN AND TEMPERATURE PROCESSING IN DEMENTIA (2015) (0)
- Journal Pre-proof Bilateral Nucleus Basalis of Meynert Deep Brain Stimulation for dementia with Lewy bodies A Randomised Clinical Trial A (2020) (0)
- Quality of Life Assessment Schedule (QoLAS) 2001 (2004) (0)
- Molecular genetic study of familial presenile dementias (1991) (0)
- Microsatellite D21S210 (GT‐12) allele frequencies in sporadic Alzheimer's disease (1995) (0)
- Asistencia a los pacientes jovenes con demencia en el National Hospital for Neurology and Neurosurgery de Londres (1998) (0)
- Creation of a Fibroblast Resource for Dementia Research (2012) (0)
- Patterns of longitudinal neuroanatomical change in genetic FTD: results from the Genetic FTD Initiative (GENFI) (2016) (0)
- CEREBRAL PERFUSION AS AN IMAGING BIOMARKER OF PRESYMPTOMATIC GENETIC FRONTOTEMPORAL DEMENTIA: PRELIMINARY RESULTS FROM THE GENETIC FRONTOTEMPORAL DEMENTIA INITIATIVE (GENFI) (2016) (0)
- Survival in Alzheimer Disease—Reply (2005) (0)
- Degenerative diseases - Editorial comment (1996) (0)
- Neurobiology of Vasopressin. Current Topics in Neuroendocrinology Series Vol 4. (1986) (0)
- Neurology in motion. (2013) (0)
- Potassium channel antibodies encephalopathy - A treatable dementia (2006) (0)
- Volumetry of the cerebellum and its subregions in genetic frontotemporal dementia (2015) (0)
- Herpes simplex virus and rates of cognitive decline or whole brain atrophy in the Dominantly Inherited Alzheimer Network (2022) (0)
- IN 2014 CAN WE PREVENT DEMENTIA? (2013) (0)
- FAMILIAL ALZHEIMERS-DISEASE VERSUS SPORADIC ALZHEIMERS-DISEASE - A CLINICAL, NEUROPSYCHOLOGICAL AND PET STUDY (1993) (0)
- A LONGITUDINAL MORPHOMETRIC STUDY OF FAMILIAL ALZHEIMER’S DISEASE: RESULTS FROM DIAN (2016) (0)
- DIADEM / Participants Directory (2004) (0)
- Recognition of emotions in faces, voices and music in frontotemporal lobar regeneration [Abstract] (2007) (0)
- Validation of next-generation sequencing technologies to radically change dementia genetic diagnosis (2013) (0)
- Everyday life in a drug trial (1991) (0)
- Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2017) (0)
- Parallel randomized controlled feasibility trials of the “Active Brains” digital intervention to protect cognitive health in adults aged 60–85 (2022) (0)
- Epidemiology and subtypes of dementia (2021) (0)
- Phenotypic variations in frontotemporal dementia caused by exon 10+16 splice site tau mutation (2000) (0)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia (2018) (0)
- Clinical and pathological features of frontotemporal lobar degeneration with FUS-positive inclusions (2010) (0)
- 595 Rates of brain atrophy measured by registration and subtraction of serial 3D MR scans correlate with clinical decline in Alzheimer's disease and related disorders (1996) (0)
- Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (2020) (0)
- 1-12-21 Registration of serial MRI detects pre-symptomatic brain atrophy in familial Alzheimer's disease (1997) (0)
- 354 A community based epidemiological study of neurological diagnosis in pre-senile dementia (1996) (0)
- 333 Slowing the progression of Alzheimer's disease — Clinical issues (1996) (0)
- Theassociation ofgegenhalten intheupperlimbs with dyspraxia (1988) (0)
- Clustering and age of onset in familial late onset Alzheimer`s disease are determined at the apoliopoprotein E locus (1994) (0)
- Biological Aspects of Alzheimer's Disease Robert Katzman (1984) (0)
- CLINICAL HETEROGENEITY IN FAMILIAL ALZHEIMERS-DISEASE (1994) (0)
- Intravenous amiodarone in atrial fibrillation complicating myocardial infarction. (1982) (0)
- New Concepts in Alzheimer's Disease. (Pierre Fabre Monograph Series Vol 1.) (1987) (0)
- Advancing Frontiers in Alzheimer's Disease Research (1988) (0)
- Cerebral ageing (1987) (0)
- New year, new editorial team Contribution of cerebral amyloid angiopathy to Alzheimer’s disease (2003) (0)
- Faculty Opinions recommendation of Association of brain pathology with the progression of frailty in older adults. (2013) (0)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
- P 01-07 BLOCKING GSK 3 b-MEDIATED DRP 1 PHOSPHORYLATION PROVIDES NEUROPROTECTION AND RESCUES MEMORY DEFICITS IN APPSWE / PS 1 DE 9 TRANSGENIC MICE (2013) (0)
- BOOK REVIEWS (1990) (0)
This paper list is powered by the following services:
Other Resources About Martin Rossor
What Schools Are Affiliated With Martin Rossor?
Martin Rossor is affiliated with the following schools:
